Kishor Mayekar

Array ( [id] => 3994839 [patent_doc_number] => 05892027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Process for the production of neutralized polysaccharide-based polycarboxylates' [patent_app_type] => 1 [patent_app_number] => 8/913071 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892027.pdf [firstpage_image] =>[orig_patent_app_number] => 913071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013920 [patent_doc_number] => 05880106 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Oral dosing formulations of dideoxy purine nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/942660 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6131 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880106.pdf [firstpage_image] =>[orig_patent_app_number] => 942660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028050 [patent_doc_number] => 05902794 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => '8-CI cAMP as anti-cancer drug' [patent_app_type] => 1 [patent_app_number] => 8/937020 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 13592 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902794.pdf [firstpage_image] =>[orig_patent_app_number] => 937020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360048 [patent_doc_number] => 06255292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Purine nucleotide analogues, pharmaceutical compositions thereof, and methods of improving cardiac functions' [patent_app_type] => 1 [patent_app_number] => 8/875050 [patent_app_country] => US [patent_app_date] => 1997-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 8960 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255292.pdf [firstpage_image] =>[orig_patent_app_number] => 875050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011413 [patent_doc_number] => 05889178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => '2-6-diaminopurine precursors' [patent_app_type] => 1 [patent_app_number] => 8/934540 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43277 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889178.pdf [firstpage_image] =>[orig_patent_app_number] => 934540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949504 [patent_doc_number] => 05998604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Polynucleotide purification method' [patent_app_type] => 1 [patent_app_number] => 8/929620 [patent_app_country] => US [patent_app_date] => 1997-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 6880 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998604.pdf [firstpage_image] =>[orig_patent_app_number] => 929620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949736 [patent_doc_number] => 05955447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'N-alkyl-2-substituted ATP analogues for treatment of embolic disease conditions' [patent_app_type] => 1 [patent_app_number] => 8/918670 [patent_app_country] => US [patent_app_date] => 1997-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6398 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955447.pdf [firstpage_image] =>[orig_patent_app_number] => 918670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072044 [patent_doc_number] => 06069132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Phosphazole compounds' [patent_app_type] => 1 [patent_app_number] => 8/910291 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21599 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069132.pdf [firstpage_image] =>[orig_patent_app_number] => 910291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577475 [patent_doc_number] => 06447998 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => '2-Aminopyridine and 2-pyridone C-nucleosides, oligonucleotides comprising, and tests using the same oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 08/906378 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9711 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447998.pdf [firstpage_image] =>[orig_patent_app_number] => 08906378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048494 [patent_doc_number] => 05968912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Methods for immunosuppressing' [patent_app_type] => 1 [patent_app_number] => 8/906138 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9229 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968912.pdf [firstpage_image] =>[orig_patent_app_number] => 906138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4068531 [patent_doc_number] => 06008386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => '.alpha.-Oxiranyl amino acids and their synthesis' [patent_app_type] => 1 [patent_app_number] => 8/898317 [patent_app_country] => US [patent_app_date] => 1997-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11669 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008386.pdf [firstpage_image] =>[orig_patent_app_number] => 898317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064183 [patent_doc_number] => 05866549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => '6-O-substituted ketolides having antibacterial activity' [patent_app_type] => 1 [patent_app_number] => 8/888350 [patent_app_country] => US [patent_app_date] => 1997-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61274 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 490 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866549.pdf [firstpage_image] =>[orig_patent_app_number] => 888350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3952087 [patent_doc_number] => 05955597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Chirally enriched synthetic phosphate oligomers' [patent_app_type] => 1 [patent_app_number] => 8/885126 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19286 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955597.pdf [firstpage_image] =>[orig_patent_app_number] => 885126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966133 [patent_doc_number] => 05885957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Treatment of HTLV-I infections' [patent_app_type] => 1 [patent_app_number] => 8/882888 [patent_app_country] => US [patent_app_date] => 1997-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3464 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885957.pdf [firstpage_image] =>[orig_patent_app_number] => 882888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935675 [patent_doc_number] => 05939537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Acid-functionalized saccharide monomers' [patent_app_type] => 1 [patent_app_number] => 8/881955 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5658 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939537.pdf [firstpage_image] =>[orig_patent_app_number] => 881955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216260 [patent_doc_number] => 06110902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine' [patent_app_type] => 1 [patent_app_number] => 8/881038 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8954 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110902.pdf [firstpage_image] =>[orig_patent_app_number] => 881038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004279 [patent_doc_number] => 06004939 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Methods for modulation and inhibition of telomerase' [patent_app_type] => 1 [patent_app_number] => 8/879457 [patent_app_country] => US [patent_app_date] => 1997-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 22327 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004939.pdf [firstpage_image] =>[orig_patent_app_number] => 879457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034150 [patent_doc_number] => 05942497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Purine compound and catecholamine compound containing compositions and methods for administration' [patent_app_type] => 1 [patent_app_number] => 8/867370 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 30 [patent_no_of_words] => 12653 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942497.pdf [firstpage_image] =>[orig_patent_app_number] => 867370 [rel_patent_id] =>[rel_patent_doc_number] =>)